Fluvastatin



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hypercholesterolaemia 20.9%
Hypertension 13.9%
Hyperlipidaemia 12.3%
Dyslipidaemia 8.6%
Pruritus 5.3%
Blood Cholesterol Increased 4.8%
Coronary Artery Disease 4.3%
Diabetes Mellitus 4.3%
Cerebrovascular Spasm 3.2%
Osteoporosis Postmenopausal 3.2%
Type 2 Diabetes Mellitus 2.7%
Abdominal Pain Upper 2.1%
Cardiovascular Disorder 2.1%
Lipids Abnormal 2.1%
Myalgia 2.1%
Heart Transplant 1.6%
Hepatitis C 1.6%
Nasopharyngitis 1.6%
Rash 1.6%
Renal Failure 1.6%
Myalgia 24.7%
Rhabdomyolysis 9.9%
Liver Disorder 8.6%
Vomiting 7.4%
Rash 6.2%
Cardiac Arrest 3.7%
Oesophageal Hypomotility 3.7%
Thrombotic Thrombocytopenic Purpura 3.7%
Uveitis 3.7%
White Blood Cell Count Decreased 3.7%
Blood Creatine Phosphokinase Increased 2.5%
Cardiac Failure 2.5%
Cerebellar Haematoma 2.5%
Muscle Spasms 2.5%
Musculoskeletal Stiffness 2.5%
Neutrophil Count Decreased 2.5%
Oedema 2.5%
Pain In Extremity 2.5%
Photocoagulation 2.5%
Pyrexia 2.5%
Secondary
Hyperlipidaemia 17.7%
Product Used For Unknown Indication 15.1%
Hypertension 12.8%
Hypercholesterolaemia 10.0%
Drug Use For Unknown Indication 9.4%
Type 2 Diabetes Mellitus 5.3%
Prophylaxis 4.0%
Glomerulonephritis 3.7%
Blood Cholesterol Increased 2.9%
Type Iib Hyperlipidaemia 2.6%
Diabetes Mellitus 2.2%
Dyslipidaemia 2.1%
Immune Thrombocytopenic Purpura 2.1%
Thrombotic Cerebral Infarction 2.0%
Bipolar Disorder 1.6%
Type Iia Hyperlipidaemia 1.6%
Nephrotic Syndrome 1.3%
Osteoarthritis 1.3%
Coronary Artery Disease 1.2%
Osteoporosis Prophylaxis 1.1%
Vomiting 18.1%
Amyotrophic Lateral Sclerosis 13.0%
Rash 10.9%
Pyrexia 6.5%
Talipes 6.5%
Rhabdomyolysis 5.8%
Musculoskeletal Discomfort 4.3%
Myalgia 4.3%
Vision Blurred 4.3%
Myopathy 2.9%
Transaminases Increased 2.9%
Vascular Graft 2.9%
Completed Suicide 2.2%
Drug Tolerance 2.2%
Hepatic Function Abnormal 2.2%
Hepatocellular Injury 2.2%
Interstitial Lung Disease 2.2%
Lung Disorder 2.2%
Nephropathy Toxic 2.2%
Polyneuropathy 2.2%
Concomitant
Product Used For Unknown Indication 22.0%
Hypertension 15.9%
Drug Use For Unknown Indication 11.0%
Renal Transplant 6.2%
Prophylaxis Against Transplant Rejection 4.7%
Diabetes Mellitus 3.9%
Type 2 Diabetes Mellitus 3.6%
Acute Myocardial Infarction 3.5%
Prophylaxis 3.4%
Hyperlipidaemia 3.3%
Multiple Myeloma 2.8%
Atrial Fibrillation 2.8%
Hypercholesterolaemia 2.5%
Immunosuppression 2.4%
Pain 2.2%
Osteoporosis 2.1%
Rheumatoid Arthritis 2.1%
Depression 2.1%
Insomnia 1.7%
Non-small Cell Lung Cancer 1.7%
Renal Failure Acute 9.8%
Pyrexia 8.1%
Syncope 7.7%
Vomiting 7.3%
Pneumonia 6.4%
Pain In Extremity 5.6%
Weight Decreased 5.6%
Urinary Tract Infection 5.1%
Myocardial Infarction 4.7%
Pancreatitis Acute 4.7%
Cerebrovascular Accident 4.3%
Nausea 4.3%
Sepsis 4.3%
Hepatic Function Abnormal 3.8%
Hyponatraemia 3.8%
Atrial Fibrillation 3.0%
Death 3.0%
Transplant Rejection 3.0%
Tremor 3.0%
Cardiac Failure 2.6%
Interacting
Hypertension 20.0%
Bipolar I Disorder 10.0%
Age-related Macular Degeneration 6.7%
Heart Transplant 6.7%
Lipids Increased 6.7%
Prophylaxis 6.7%
Acidosis 3.3%
Anaemia 3.3%
Cardiac Failure 3.3%
Drug Use For Unknown Indication 3.3%
Dyslipidaemia 3.3%
Helicobacter Gastritis 3.3%
Hiccups 3.3%
Hypercholesterolaemia 3.3%
Hyperlipidaemia 3.3%
Hyperparathyroidism Secondary 3.3%
Hyperuricaemia 3.3%
Immunosuppressant Drug Therapy 3.3%
Renal Transplant 3.3%
Visual Acuity Reduced 22.2%
White Blood Cell Count Increased 22.2%
Blood Creatine Phosphokinase Increased 11.1%
Renal Failure Chronic 11.1%
Rhabdomyolysis 11.1%
Tachypnoea 11.1%
Vomiting 11.1%